, Tracking Stock Market Picks
Enter Symbol:
Omeros Corporation (OMER) [hlAlert]

up 58.87 %

Omeros Corporation (OMER) rated Buy with price target $28 by Maxim Group

Posted on: Thursday,  Nov 13, 2014  9:25 AM ET by Maxim Group

Maxim Group rated Buy Omeros Corporation (NASDAQ: OMER) on 11/13/2014. Previously Maxim Group rated Buy Omeros Corporation (NASDAQ: OMER) on 05/08/2012.,
when the stock price was $9.92. Since then, Omeros Corporation has gained 58.87% as of 01/26/2016's recent price of $15.76.
If you would have followed the previous Maxim Group's recommendation on OMER, you would have gained 58.87% of your investment in 1358 days.

Omeros Corporation is a clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company?s clinically advanced product candidates are derived from its PharmacoSurgerytm platform designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Its PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/13/2014 9:25 AM Buy
19.75 28.00
as of 10/17/2014
1 Week up  2.79 %
1 Month down  -2.78 %
3 Months down  -2.85 %
1 YTD up  17.36 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/30/2012 8:25 AM Buy
9.42 25.00
7/30/2012 8:25 AM Buy
9.42 25.00
7/23/2012 8:29 AM Buy
8.73 25.23
5/8/2012 9:25 AM Buy
9.92 23.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy